A critical advance in cancer investigation is occurring with the use of nanobodies to re-engage damaged p53. This essential malignant inhibitor protein is frequently disabled in various forms of cancer, leading https://rotatesites.com/story23530498/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-hope-for-malignant-therapy